Sargiannidou I - Search Results

1

Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.

Schiza N, Georgiou E, Kagiava A, Médard JJ, Richter J, Tryfonos C, Sargiannidou I, Heslegrave AJ, Rossor AM, Zetterberg H, Reilly MM, Christodoulou C, Chrast R, Kleopa KA. Schiza N, et al. Among authors: sargiannidou i. Brain. 2019 May 1;142(5):1227-1241. doi: 10.1093/brain/awz064. Brain. 2019. PMID: 30907403 Free PMC article.

2

Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants.

Sargiannidou I, Ahn M, Enriquez AD, Peinado A, Reynolds R, Abrams C, Scherer SS, Kleopa KA. Sargiannidou I, et al. Neurobiol Dis. 2008 May;30(2):221-33. doi: 10.1016/j.nbd.2008.01.009. Epub 2008 Feb 15. Neurobiol Dis. 2008. PMID: 18353664 Free PMC article.

3

Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects.

Sargiannidou I, Vavlitou N, Aristodemou S, Hadjisavvas A, Kyriacou K, Scherer SS, Kleopa KA. Sargiannidou I, et al. J Neurosci. 2009 Apr 15;29(15):4736-49. doi: 10.1523/JNEUROSCI.0325-09.2009. J Neurosci. 2009. PMID: 19369543 Free PMC article.

4

Molecular mechanisms of gap junction mutations in myelinating cells.

Sargiannidou I, Markoullis K, Kleopa KA. Sargiannidou I, et al. Histol Histopathol. 2010 Sep;25(9):1191-206. doi: 10.14670/HH-25.1191. Histol Histopathol. 2010. PMID: 20607661 Review.

5

Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy.

Vavlitou N, Sargiannidou I, Markoullis K, Kyriacou K, Scherer SS, Kleopa KA. Vavlitou N, et al. Among authors: sargiannidou i. J Neuropathol Exp Neurol. 2010 Sep;69(9):945-58. doi: 10.1097/NEN.0b013e3181efa658. J Neuropathol Exp Neurol. 2010. PMID: 20720503 Free PMC article.

6

Gap junction disorders of myelinating cells.

Kleopa KA, Orthmann-Murphy J, Sargiannidou I. Kleopa KA, et al. Among authors: sargiannidou i. Rev Neurosci. 2010;21(5):397-419. doi: 10.1515/revneuro.2010.21.5.397. Rev Neurosci. 2010. PMID: 21280457 Review.

7

Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.

Markoullis K, Sargiannidou I, Gardner C, Hadjisavvas A, Reynolds R, Kleopa KA. Markoullis K, et al. Among authors: sargiannidou i. Glia. 2012 Jul;60(7):1053-66. doi: 10.1002/glia.22334. Epub 2012 Mar 27. Glia. 2012. PMID: 22461072

8

Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.

Markoullis K, Sargiannidou I, Schiza N, Hadjisavvas A, Roncaroli F, Reynolds R, Kleopa KA. Markoullis K, et al. Among authors: sargiannidou i. Acta Neuropathol. 2012 Jun;123(6):873-86. doi: 10.1007/s00401-012-0978-4. Epub 2012 Apr 7. Acta Neuropathol. 2012. PMID: 22484441

9

Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.

Markoullis K, Sargiannidou I, Schiza N, Roncaroli F, Reynolds R, Kleopa KA. Markoullis K, et al. Among authors: sargiannidou i. J Neuropathol Exp Neurol. 2014 Sep;73(9):865-79. doi: 10.1097/NEN.0000000000000106. J Neuropathol Exp Neurol. 2014. PMID: 25101702

10

Gene delivery targeted to oligodendrocytes using a lentiviral vector.

Kagiava A, Sargiannidou I, Bashiardes S, Richter J, Schiza N, Christodoulou C, Gritti A, Kleopa KA. Kagiava A, et al. Among authors: sargiannidou i. J Gene Med. 2014 Nov-Dec;16(11-12):364-73. doi: 10.1002/jgm.2813. J Gene Med. 2014. PMID: 25394283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page